PCSK9 and metabolic dysfunction-associated steatohepatitis: In recent years, NAFLD and nonalcoholic steatohepatitis development were shown to be associated with cardiovascular dysfunction and remodeling.39, 40, 41, 42 Increased PCSK9 levels were observed to be associated with hepatic fat accumulation in humans.20